Targeted therapies: optimal first-line therapy for NSCLC with EGFR mutations (Q43179196)
Jump to navigation
Jump to search
scientific article published in February 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Targeted therapies: optimal first-line therapy for NSCLC with EGFR mutations |
scientific article published in February 2010 |
Statements
1 reference
Targeted therapies: optimal first-line therapy for NSCLC with EGFR mutations (English)
1 reference
Lecia V Sequist
1 reference
Joel W Neal
1 reference
1 February 2010
1 reference
1 reference
7
1 reference
2
1 reference
71-72
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference